TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nord Vacc Läkemedel AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
951
|
663
|
580 |
| Financial expenses |
8
|
9
|
1 |
| Earnings before taxes |
-295
|
-923
|
-67 |
| EBITDA |
-286
|
-910
|
-92 |
| Total assets |
543
|
460
|
769 |
| Current assets |
540
|
456
|
614 |
| Current liabilities |
186
|
166
|
129 |
| Equity capital |
41
|
29
|
51 |
| - share capital |
41
|
42
|
42 |
| Employees (average) |
3
|
2
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
7.6%
|
6.3%
|
6.6% |
| Turnover per employee |
317
|
332
|
193 |
| Profit as a percentage of turnover |
-31.0%
|
-139.2%
|
-11.6% |
| Return on assets (ROA) |
-52.9%
|
-198.7%
|
-8.6% |
| Current ratio |
290.3%
|
274.7%
|
476.0% |
| Return on equity (ROE) |
-719.5%
|
-3182.8%
|
-131.4% |
| Change turnover |
310
|
82
|
162 |
| Change turnover % |
48%
|
14%
|
39% |
| Chg. No. of employees |
1
|
-1
|
0 |
| Chg. No. of employees % |
50%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.